These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Genetic therapy for beta-thalassemia: from the bench to the bedside. Arumugam P; Malik P Hematology Am Soc Hematol Educ Program; 2010; 2010():445-50. PubMed ID: 21239833 [TBL] [Abstract][Full Text] [Related]
44. Gene therapy for the hemoglobin disorders. Persons DA; Nienhuis AW Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333 [TBL] [Abstract][Full Text] [Related]
45. Towards more successful gene therapy clinical trials for β-thalassemia. Drakopoulou E; Papanikolaou E; Georgomanoli M; Anagnou NP Curr Mol Med; 2013 Sep; 13(8):1314-30. PubMed ID: 23865429 [TBL] [Abstract][Full Text] [Related]
46. Hemoglobin gene therapy for β-thalassemia. Bank A Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288 [TBL] [Abstract][Full Text] [Related]
47. Gene therapy for hemoglobinopathies: are we there yet? Puthenveetil G; Malik P Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560 [TBL] [Abstract][Full Text] [Related]
49. Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements. Wang H; Georgakopoulou A; Li C; Liu Z; Gil S; Bashyam A; Yannaki E; Anagnostopoulos A; Pande A; Izsvák Z; Papayannopoulou T; Lieber A JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814708 [TBL] [Abstract][Full Text] [Related]
50. Treating hemoglobinopathies using gene-correction approaches: promises and challenges. Cottle RN; Lee CM; Bao G Hum Genet; 2016 Sep; 135(9):993-1010. PubMed ID: 27314256 [TBL] [Abstract][Full Text] [Related]
51. Lentiviral Transfer of γ-Globin with Fusion Gene NUP98-HOXA10HD Expands Hematopoietic Stem Cells and Ameliorates Murine β-Thalassemia. Zhao HF; Abraham A; Kim YS; Wang YD; Pestina T; Zhan J; Humphries K; Nienhuis AW; Persons DA Mol Ther; 2017 Mar; 25(3):593-605. PubMed ID: 28190779 [TBL] [Abstract][Full Text] [Related]
52. Historical Perspective on the Current Renaissance for Hematopoietic Stem Cell Gene Therapy. Kohn DB Hematol Oncol Clin North Am; 2017 Oct; 31(5):721-735. PubMed ID: 28895843 [TBL] [Abstract][Full Text] [Related]
54. Gene Therapy for Hemoglobinopathies: Beta-Thalassemia, Sickle Cell Disease. Leonard A; Tisdale JF; Bonner M Hematol Oncol Clin North Am; 2022 Aug; 36(4):769-795. PubMed ID: 35773052 [TBL] [Abstract][Full Text] [Related]
55. Comparative analysis of FV vectors with human α- or β-globin gene regulatory elements for the correction of β-thalassemia. Morianos I; Siapati EK; Pongas G; Vassilopoulos G Gene Ther; 2012 Mar; 19(3):303-11. PubMed ID: 21734726 [TBL] [Abstract][Full Text] [Related]
60. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia. Bank A; Dorazio R; Leboulch P Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]